The Cellular Mechanics of an Ageing Heart: From Senescence to Stiffness
A comprehensive review in the European Heart Journal details the complex molecular and cellular pathology underlying myocardial ageing, a process distinct from overt disease. The article synthesizes evidence on how cellular senescence, driven by factors like telomere shortening and mitochondrial dysfunction, leads to a loss of cardiomyocytes and compensatory hypertrophy. This results in increased myocardial stiffness and altered muscle function. The review further connects these direct tissue morphology changes to secondary clinical consequences, including valvular calcification, fibrosis leading to arrhythmias, and vascular abnormalities exacerbating hypertension. It emphasizes the role of biomarkers, such as non-coding RNAs and extracellular vesicles, in driving fibrosis through matrix remodelling, highlighting the intersection of molecular diagnostics and anatomic pathology in understanding organ-level decline.
Study Significance: For pathologists, this framework is crucial for differentiating age-related physiological changes from early, preventable pathological states during autopsy or biopsy analysis. Understanding these distinct trajectories of myocardial ageing can refine tumor grading and staging paradigms for cardiac tumors by providing a clearer baseline of normal senescence. It also underscores the growing importance of molecular pathology techniques, like assessing non-coding RNA biomarkers, in diagnostic panels to predict tissue vulnerability and fibrosis risk beyond traditional histopathology.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
